Everything below concerns freeze-thaw. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Updated 2026-01-03. Numbers and descriptions here follow the published literature rather than marketing material.
Temperature is a primary factor because most degradation reactions proceed more slowly at lower temperatures. Lyophilized peptides are commonly held at -20 °C or below, although some sequences remain stable at 2–8 °C for limited periods. Moisture uptake during handling can accelerate hydrolysis, so sealed containers and desiccants are used. Solutions are generally less stable than powders and may require freezing at -80 °C or refrigeration, depending on the peptide. Repeated freeze-thaw cycles can promote aggregation even when the storage temperature is otherwise suitable.
Light, oxygen, and pH influence peptide integrity through specific side-chain reactions. Methionine and cysteine residues are susceptible to oxidation, and tryptophan can degrade under strong light. Inert gas overlays and amber glass or opaque containers reduce these risks. pH affects charge, solubility, and the rate of deamidation or aggregation; a value that minimizes one pathway may increase another. The optimal pH and buffer for a given peptide are often determined experimentally, and open questions remain about predicting stability from sequence alone.
Peptides are short chains of amino acids that can undergo both chemical and physical degradation. Chemical pathways include hydrolysis of peptide bonds, oxidation of methionine or cysteine residues, deamidation of asparagine or glutamine, and isomerization of aspartate. Physical instability leads to aggregation, precipitation, or adsorption to surfaces. The rate of these processes depends on the peptide sequence, the formulation, and the storage environment. Because each peptide has a unique composition, no single storage condition applies to all peptides. Stability studies are therefore conducted to define suitable conditions for each specific molecule.
Temperature is a primary factor in peptide storage. Lower temperatures reduce molecular motion and slow degradation reactions, but freezing can concentrate solutes and promote aggregation. Lyophilized powders are commonly held at -20°C, whereas solutions are often kept at -80°C. Repeated freeze-thaw cycles are harmful because ice crystal formation and pH shifts can damage the peptide. The glass transition temperature of a lyophilized cake influences its stability; below this temperature, molecular mobility is restricted. For solutions, the choice between -20°C and -80°C depends on the peptide's sensitivity and the intended storage duration.
| Property | Value | Notes |
|---|---|---|
| Appearance (lyophilized) | White to off-white powder | May appear fluffy, crystalline, or amorphous depending on manufacturing |
| Solubility class | Typically water-soluble | Solubility varies with sequence and pH; some require organic co-solvents |
| Typical storage temperature (lyophilized) | -20 °C or lower | Some peptides tolerate 2–8 °C; moisture control is critical |
| Typical storage temperature (solution) | -80 °C to 2–8 °C | Depends on peptide; avoid repeated freeze-thaw cycles |
| Common analytical method | Reverse-phase HPLC | Used for purity, identity, and degradation monitoring; mass spectrometry often confirms mass |
When a peptide arrives, the vial should be inspected for damage, and its label, lot number, and accompanying analytical data should be recorded. Cold vials should equilibrate to room temperature before opening to prevent condensation on the powder. Moisture uptake can reduce stability and complicate accurate weighing or reconstitution. Inventory systems that track date, quantity, and storage location help prevent unnecessary temperature cycling. Personnel should follow institutional or manufacturer instructions for any specific peptide.
Reconstitution is often performed with sterile water, buffer, or a water-miscible organic solvent, depending on solubility. The solvent should be added gently along the vial wall, and the solution mixed by gentle swirling rather than vigorous vortexing, which can cause foaming and surface denaturation. Some sequences require a small amount of base or acid to dissolve, followed by pH adjustment. Preparing a concentrated stock solution can simplify later dilution, but the stock itself may have limited stability. Records of solvent, concentration, and date support reproducibility.
After reconstitution, dividing the solution into single-use aliquots limits multiple warming and cooling events and reduces contamination risk. Low-binding polypropylene tubes are often preferred because peptides can adsorb to glass or untreated plastic surfaces. Filling headspace with nitrogen or argon can slow oxidation, and amber or foil-wrapped containers reduce photodegradation. Each aliquot should be labeled with peptide identity, concentration, date, and storage conditions. Frozen aliquots should be thawed quickly and kept on ice until use.
Peptides are short chains of amino acids linked by amide bonds. Their stability depends on sequence, length, and the chemical environment. Common degradation routes include hydrolysis of the peptide backbone, oxidation of methionine or cysteine residues, deamidation of asparagine or glutamine, and aggregation through hydrophobic or electrostatic interactions. These processes can alter mass, charge, or biological activity, so storage conditions aim to slow them. The relative importance of each route varies widely among peptides.
Water is a central factor in peptide degradation because it enables hydrolysis and mobilizes reactive species. Lyophilized or dry powders typically remain stable for longer than solutions when kept cool and dry. Oxygen can drive oxidation, particularly for sulfur-containing residues, while light can catalyze side-chain damage. Buffer choice and pH influence charge state and can accelerate or slow deamidation and aggregation. Freeze-thaw cycles may concentrate solutes or promote ice-induced aggregation, so minimizing such cycles is a common handling goal.
== Specials == 空山鳥語 - kōngshān niǎo yǔ - Birdsong in Hollow Valley 2014 This special consists of three episodes which tells the story of Baifeng and his friend Moya who were assassins for General Ji Wuye, but who turn against him after Baifeng falls for a female assassin, Nong Yu.
In a meta-analysis of 20 studies involving 1,466 patients with coronary artery disease, CRP levels were found to be reduced after exercise interventions. Among those studies, higher CRP concentrations or poorer lipid profiles before beginning exercise were associated with greater reductions in CRP. To clarify whether CRP is a bystander or active participant in atherogenesis, a 2008 study compared people with various genetic CRP variants. Those with a high CRP due to genetic variation had no increased risk of cardiovascular disease compared to those with a normal or low CRP. A study published in 2011 shows that CRP is associated with lipid responses to low-fat and high-polyunsaturated fat diets.
C6H4(CO)2NR + N2H4 → C6H4(CO)2N2H2 + RNH2 Alkyl amines can also be used. Some examples of phthalimide-containing drugs include thalidomide, amphotalide, taltrimide, talmetoprim, and apremilast. With a trichloromethylthio substituent, a phthalimide-derived fungicide is Folpet.
Sources: en.wikipedia.org
=== Strabismus === Ophthalmologists specializing in eye muscle disorders (strabismus) had developed the method of EMG-guided injection (using the electromyogram, the electrical signal from an activated muscle, to guide injection) of local anesthetics as a diagnostic technique for evaluating an individual muscle's contribution to an eye movement. Because strabismus surgery frequently needed repeating, a search was undertaken for non-surgical, injection treatments using various anesthetics, alcohols, enzymes, enzyme blockers, and snake neurotoxins. Finally, inspired by Daniel B. Drachman's work with chicks at Johns Hopkins, Alan B. Scott and colleagues injected botulinum toxin into monkey extraocular muscles. The result was remarkable; a few picograms induced paralysis that was confined to the target muscle, long in duration, and without side effects. After working out techniques for freeze-drying, buffering with albumin, and assuring sterility, potency, and safety, Scott applied to the FDA for investigational drug use, and began manufacturing botulinum type A neurotoxin in his San Francisco lab. He injected the first strabismus patients in 1977, reported its clinical utility in 1980, and had soon trained hundreds of ophthalmologists in EMG-guided injection of the drug he named Oculinum ("eye aligner"). In 1986, Oculinum Inc, Scott's micromanufacturer and distributor of botulinum toxin, was unable to obtain product liability insurance, and could no longer supply the drug. As supplies became exhausted, people who had come to rely on periodic injections became desperate.
In genomics, annotation refers to the process of marking the stop and start regions of genes and other biological features in a sequenced DNA sequence. Many genomes are too large to be annotated by hand. As the rate of sequencing exceeds the rate of genome annotation, genome annotation has become the new bottleneck in bioinformatics. Genome annotation can be classified into three levels: the nucleotide, protein, and process levels. Gene finding is a chief aspect of nucleotide-level annotation. For complex genomes, a combination of ab initio gene prediction and sequence comparison with expressed sequence databases and other organisms can be successful. Nucleotide-level annotation also allows the integration of genome sequence with other genetic and physical maps of the genome. The principal aim of protein-level annotation is to assign function to the protein products of the genome. Databases of protein sequences and functional domains and motifs are used for this type of annotation. About half of the predicted proteins in a new genome sequence tend to have no obvious function. Understanding the function of genes and their products in the context of cellular and organismal physiology is the goal of process-level annotation. An obstacle of process-level annotation has been the inconsistency of terms used by different model systems. The Gene Ontology Consortium is helping to solve this problem.
Gomphrena globosa, commonly known as globe amaranth, is an edible plant from the family Amaranthaceae. The round-shaped flower inflorescences are a visually dominant feature and cultivars have been propagated to exhibit shades of magenta, purple, red, orange, white, pink, and lilac. Within the flowerheads, the true flowers are small and inconspicuous. Gomphrena globosa is native to Central America including regions Panama, and Guatemala, but is now grown globally. As a tropical annual plant, G. globosa blooms continuously throughout summer and early fall. It is very heat tolerant and fairly drought resistant, but grows best in full sun and regular moisture. The plant fixes carbon through the C4 pathway. At maturity, the flowerheads are approximately 4 centimetres (1.6 in) long and the plant grows up to 24 inches (61 cm) in height. Gomphrena globosa is an outcrossing species that is pollinated by butterflies, bees, and other insects. Floral volatiles likely play a significant role in the reproductive success of the plant by promoting the attraction of pollinators.
Sources: en.wikipedia.org
==== Gastrointestinal and colorectal cancer ==== Reviews of preliminary clinical trials on people with colorectal or gastrointestinal cancer suggest that soy isoflavones may have a slight protective effect against such cancers.
colorimeter Also chromometer. Any instrument used for color measurement based on optical comparison with standard colors, particularly a device used in colorimetry that measures the absorbance of specific wavelengths of light by a given solution in order to determine the concentration of a known solute in the solution, by application of the principle that solute concentration is directly proportional to absorbance.
=== Memory effects === Both of these two types of mechanism can display enzyme memory, with very different causes and consequences in the two cases. In ternary complex mechanisms, these are possible if the mechanism includes slow processes and the binding steps are not at quasi-equilibrium, because the intermediates may be swept away very fast. This can generate cooperativity, even in monomeric enzymes. In a substituted-enzyme mechanism, slow steps are not needed to generate memory effects. Instead, for an enzyme with several alternative substrates, the kinetic properties of the second half reaction may vary with different substrates in the first half reaction, even though the same substituted enzyme seems to be transformed. Reversible catalysis and the Haldane equation
Sources: en.wikipedia.org
Removing water reduces hydrolytic and some oxidative degradation. Powder forms are generally more stable for long-term storage than solutions. Stability still depends on peptide sequence, residual moisture, and container conditions.
Freezing slows most chemical reactions, but it can also concentrate solutes and promote aggregation during freezing or thawing. Repeated freeze-thaw cycles are often more damaging than constant cold storage. Some peptides require specific buffers or additives to remain soluble.
pH affects charge, solubility, and the reactivity of amino acid side chains. It can influence deamidation, oxidation, and aggregation pathways. The best pH is peptide-specific and is usually identified through stability testing.
Removing water reduces hydrolytic degradation and limits microbial growth. Lyophilized powders are generally more stable at higher temperatures than aqueous solutions. They also tolerate shipping with less risk of degradation.